FR
Highly rated in
11
conditions
Highly rated in
11
conditions

About Dr. Ferdinand Roelfsema

Ferdinand Roelfsema is in Leiden, Netherlands. Dr. Roelfsema is highly rated in 11 conditions, according to our data. His top areas of expertise are Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaly, and Familial Hyperthyroidism due to Mutations in TSH Receptor.

His clinical research consists of co-authoring 122 peer reviewed articles in the past 15 years.

Locations
  Leiden, ZH, NL
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


122 Total Publications

Journal: The Journal of clinical endocrinology and metabolism
Published —April 05, 2021
Interleukin-2 Transiently Inhibits Pulsatile Growth Hormone Secretion in Young but not Older Healthy Men.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Leiden University Medical Center
 
Leiden, ZH, NL 
 0.1 km
Nienke Biermasz is in Leiden, Netherlands. They have been an author on 210 peer reviewed articles and participated in 1 clinical trial in the past 15 years.
Highly rated in
0
conditions
Leiden University Medical Center
 
Leiden, ZH, NL 2300R
 0.1 km
Victoria Delgado is in Leiden, Netherlands. They have been an author on 614 peer reviewed articles and participated in 2 clinical trials in the past 15 years.
Highly rated in
0
conditions
Leiden University Medical Center
 
Leiden, ZH, NL 
 0.1 km
Hans Gelderblom is in Leiden, Netherlands. They have been an author on 298 peer reviewed articles and participated in 120 clinical trials in the past 15 years.